59 Annual Report 2022 21 SHARE-BASED PAYMENTS The following share-based payment arrangements existed at 30 June 2022: Number of Options Exercise Price ($) Granted Date Status Vested Date Expiry Date Conditions Note 333,333 $1 .05 27-Sep-19 Vested 27-Sep-19 4-Oct-23 Yes 1 & 4 166,667 $1 .86 27-Sep-19 Vested 27-Sep-19 20-Nov-23 Yes 1 & 4 60,665 $1 .44 28-Jul-20 Vested 28-Jul-20 3-May-23 Yes 1 & 2 8,666 $1 .44 28-Jul-20 Vested 3-May-21 3-May-23 Yes 1 & 2 121,334 $ 1 . 1 9 28-Jul-20 Vested 28-Jul-20 15-Nov-23 Yes 1 & 2 48,148 $ 1 . 1 7 28-Jul-20 Vested 28-Jul-20 4-Dec-23 Yes 1 & 2 72,222 $ 1 . 1 7 28-Jul-20 Vested 4-Dec-20 4-Dec-23 Yes 1 & 2 72,222 $ 1 . 1 7 28-Jul-20 Vested 4-Dec-21 4-Dec-23 Yes 1 & 2 26,000 $0.81 28-Jul-20 Vested 28-Jul-20 2-Jul-24 Yes 1 & 2 57,200 $0.81 28-Jul-20 Vested 2-Jul-21 2-Jul-24 Yes 1 & 2 47,667 $0.81 28-Jul-20 Granted 2-Jul-22 2-Jul-24 Yes 1, 2 & 3 13,000 $0.51 28-Jul-20 Vested 6-Feb-21 6-Feb-25 Yes 1 & 2 20,222 $0.51 28-Jul-20 Vested 6-Feb-22 6-Feb-25 Yes 1 & 2 13,000 $0.51 28-Jul-20 Granted 6-Feb-23 6-Feb-25 Yes 1, 2 & 3 166,667 $ 1 . 1 3 14-Apr-21 Vested 14-Apr-21 30-Apr-25 Yes 1 & 4 50,000 $1 .46 19-Nov-21 Granted 13-Sep-22 19-Nov-25 Yes 1 & 5 1,000,000 $2.32 29-Nov-21 Granted Conditions 30-Sep-23 Yes 1 & 6 1,000,000 $3.00 29-Nov-21 Granted Conditions 30-Sep-24 Yes 1 & 7 50,000 $1 . 73 04-Jan-22 Granted 20-Sep-22 20-Sep-25 Yes 1 & 3 50,000 $1 . 73 04-Jan-22 Granted 20-Sep-23 20-Sep-25 Yes 1 & 3 50,000 $1 . 73 04-Jan-22 Granted 20-Sep-24 20-Sep-25 Yes 1 & 3 3,427,013 Total ESOP Options Placement and Share Purchase Plan Options: 5,909,965 $2.32 24-Aug-21 Vested 24-Aug-21 24-Aug-23 No 8 9,336,978 Total Options on issue Notes: 1. Issued under the terms of the INOVIQ Incentive Option Plan (ESOP). 2. Upon termination of employment, vested options expire 60 days after termination of employment other than upon death, retirement, disability, or at Board discretion. Options are to be allowed to remain exercisable until expiry upon retirement or disability. Upon death, or mental incapacity, options can be transferred to an estate, or next of kin, and allowed to remain exercisable until expiry. In case of a change of control unvested options which have not expired are deemed to have satisfied the vesting conditions. 3. Vesting basis: to remain employed by INOVIQ up until vesting date. 4. Options issued to Dr Leearne Hinch. If Dr Hinch is to leave the employment of the Group options will expire 3 months after the departure date. 5. Vesting date 12 months after the execution of a consulting agreement with INOVIQ. 6. For the options to vest (be exercisable) the 7-day volume weighted price of the Company’s Shares must reach $2.32. 7. For the options to vest (be exercisable) the 7-day volume weighted price of the Company’s Shares must reach $3.00. 8. Options issued to Placement and Share Purchase Plan participants. All options granted are in respect of ordinary shares in INOVIQ Limited and confer a right of one ordinary share for each option held. Per the terms and conditions of the Incentive Option Plan, directors retain the right to vary the terms of issued options as long as the variation does not result in a lessening of the holder’s rights.
RkJQdWJsaXNoZXIy MjE2NDg3